Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials
Most epilepsy patients wait a year after starting treatment for seizure relief - EurekAlert!
Are patients with advanced cancer receiving treatment aligned with their goals? - EurekAlert!
Mount Everest Air Offers Clues to Parkinson’s Treatment
A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply
New gene linked to aggressive, treatment-resistant prostate cancer - EurekAlert!
New tool aims to improve lung cancer prevention, screening, and treatment - EurekAlert!
Treatment for obstructive sleep apnea lowers heart risk for some patients, increases risk for others - EurekAlert!
Immune-dodging cells could give diabetes treatment a shot in the arm
Most primary care patients with opioid use disorder who start treatment stay engaged - EurekAlert!
Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatment - EurekAlert!
FAU researchers advise: prescribe high potency statins in treatment, prevention - EurekAlert!
Ancient desert berry unlocks new hope for diabetes treatment - EurekAlert!
Study paves path to improved diagnosis, treatment of NUT carcinoma - EurekAlert!
Improving colorectal cancer prevention and treatment for Black Americans - EurekAlert!
An Inventor Is Injecting Bleach Into Cancerous Tumors—and Wants to Bring the Treatment to the US
Guided Nanoparticles Reconnect Brain Cells, Raising Hopes For Parkinson's Treatment
Weight loss benefits of Tirzepatide persist after stopping treatment in Chinese adults - EurekAlert!
Health: Anti-obesity medications associated with weight rebound post-treatment - EurekAlert!
